Clinical Dialysis Articles & Analysis
7 news found
During the event, Medical Indicators will meet with attendees to show why our clinically accurate, single-use thermometers have been trusted by top hospitals, dialysis centers, and medical clinics around the world for more than 40 years. ...
The Bridging the Gap report makes five landmark recommendations on how the NHS can support more people who are clinically suitable to do home dialysis, offering improved clinical outcomes, quality of life and reducing costs. ...
Quanta Dialysis Technologies Ltd (“Quanta” of the “Company”, a medical technology company committed to making kidney care more accessible with its SC+ haemodialysis system, announced today the results of the UK Dialysis Patient Experience Survey, showing the wide variance in care experienced by UK dialysis patients, as ...
CloudCath, developer of a remote monitoring and predictive analytics platform for catheter-based treatments, today announced a collaboration with American Renal Associates (ARA), a leading provider of outpatient dialysis services. In a U.S.- based, pre-market clinical study, ARA will evaluate the use of CloudCath’s System by peritoneal ...
Hospital outpatient departments, ambulatory surgical centers, dialysis clinics, physician and health professional offices, and other teams that perform medical services on an outpatient basis can use these tools to easily communicate across staff, safety, quality, risk, and compliance teams, improve the reporting rate of patient, staff, and visitor events, and ...
Therefore, in order to improve our efficiency at all levels, Fameco GME and Fameco Clinical have merged into one sole division: Fameco Medical. Up to this point, Fameco GME was specialized in hospital equipment such as anaesthesia, ventilation, endoscopy and dialysis whereas Fameco Clinical was the division dedicated to the ...
ByFameco
Invizius stems from years of research by Invizius co-founder, Dr Andy Herbert and his team, who believe they have found a way to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis. The investment will allow the company to build its team and take the product to the next stage of development in preparation for clinical trials. ...